Healthcare -
Biotechnology - NASDAQ - US
$ 2.725
0.408 %
$ 174 M
Market Cap
-1.63
P/E
LRMR - OPERATING INCOME
Operating Income LRMR - Larimar Therapeutics, Inc.
-90.9 M
LAST VALUE
-57.75%
2 YEAR CAGR
-31.39%
5 YEAR CAGR
-9.85%
10 YEAR CAGR